REQUEST A DEMO
Total
USD $0.00
Search more companies

Karleny S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Ophthalmic Goods Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Karleny S.A. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Karleny S.A. is based in Ecuador, with the head office in La Libertad. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on June 06, 2022. 2 (2023) employees currently work for Karleny S.A.. From the latest financial highlights, Karleny S.A. reported a net sales revenue drop of 35.58% in 2023. During that time, Karleny S.A.’s total assets grew by 4.25%. The net profit margin of Karleny S.A. decreased by 33.57% in 2023.

Headquarters
Calle 27 y 28 24
La Libertad; Santa Elena;

Contact Details: Purchase the Karleny S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Karleny S.A. report to view the information.
Outstanding Shares:
Purchase the Karleny S.A. report to view the information.
Registered Capital:
Purchase the Karleny S.A. report to view the information.
Incorporation Date:
June 06, 2022
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Karleny S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-35.58%
Total operating revenue
-35.58%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-82.72%
Total assets
4.25%
Total equity
17.12%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-33.57%
Return on Equity (ROE)
-84.45%
Quick Ratio
1.02%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?